Quantification of betacellulin levels with ELISA
Betacellulin levels of concentrated media samples were measured using Dual Set ELISA kit (R&D Systems) according to manufacturer's instructions. Briefly, a 96-well plate was coated with a capture antibody. After washing and blocking steps, standards or normalized samples were loaded. This was followed by the addition of a detection antibody, HRP, and a substrate solution. The absorption was measured by a plate reader.
Transient transfection
ADAM10 was knocked down by reverse transfection using oligofectamine (Invitrogen) and ADAM10 specific siRNA or scramble (Sigma Aldrich). Cells were incubated for 48h to assess mRNA levels; for 72h to do western blot analysis; and for 5 days to investigate the effect of knockdown on cell number.
qRT-PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. Samples were treated with DNase I (Bio-Rad Lab.). The High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was used for cDNA synthesis. Gene expression levels were normalized relative to actin.
Immunohistochemistry staining
After re-hydration, citrate buffer (pH6) was used for antigen retrieval. The ADAM10 antibody (Abcam) was applied overnight at 4°C. Slides were washed with PBS before adding the secondary antibody (ImmPress TM Reagent Anti-Rabbit IgG, Vector Laboratories Inc.). DAB Peroxidase substrate) was added and slides were counterstained with hematoxylin QS (Vector Laboratories Inc.) Slides were scored using the immunoreactive score of Remmele and Stegner (IRS) (3).
Xenograft studies
Xenograft experiments comparing trastuzumab treatment with the vehicle control were described earlier (4) . Animal experiments, using an allosteric AKT/PKB inhibitor (AKTi), were hours. Tumor samples were collected and fixed in formalin.
